Idelvion (coagulation factor IX [recombinant], albumin fusion protein) is a prescription drug used to treat and help prevent bleeding episodes in people with hemophilia B. Idelvion is given as an ...

Hemophilia B causes a deficiency in factor IX, a protein necessary for blood clotting. Replacement factor IX therapy is the gold standard treatment, but novel and genetic therapies are showing promise ...

Hemophilia B, also known as Christmas disease, is a bleeding disorder. Its characteristic feature is a deficiency of clotting factor IX. This is a protein present in the blood that helps with ...

Hemophilia B is a rare X-chromosome-linked bleeding disorder caused by mutations in the blood clotting factor IX that reduce its circulating levels in blood. A clinical trial led by experts at the ...

After blood vessel damage, effective blood clotting is essential to halt bleeding. However, this process is inefficient in some individuals due to hereditary factors. Hemophilia B, for example, ...

Hemophilia A is caused by a shortage of clotting factor VIII, while Hemophilia B results from a deficiency in clotting factor IX. Both types are inherited, and their severity may differ. Acquired ...

Haemophilia B constitutes a severe rare genetic bleeding condition which interferes strongly with blood clotting mechanisms. People who receive early diagnosis and receive effective treatment while ...